Keiko Okada
About
Keiko Okada is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology.
According to data from OpenAlex, Keiko Okada has authored 41 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in Keiko Okada's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Keiko Okada is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Keiko Okada collaborates with scholars based in Japan, United States and Italy. Keiko Okada's co-authors include Junichi Hara, Katsutoshi Yoshizato, Yuka Miyamoto, Dan Bach Kristensen, Mutsumi Inamatsu, Kai Yamasaki, Tetsuya Sano, Toshinori Nishigaki, Kouji Matsuzaki and Hiroyuki Fujisaki and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and British Journal of Haematology.
In The Last Decade
Keiko Okada
39 papers receiving 395 citations
Peers
Keiko Okada
Henry Hui Australia
Laura Rodríguez‐Romo Mexico
Toshio Kakihara Japan
Toshiaki Ishida Japan
Nozomu Kawashima Japan
Jung Yeon Lee South Korea
Djuna Z. de Back Netherlands
S Miyazaki Japan
Emily K. Thomas United States
Takamitsu Matsushima Japan
Citations per year, relative to Keiko Okada Keiko Okada (= 1×)
peers
Henry Hui
Countries citing papers authored by Keiko Okada
Since
Specialization
Citations
This map shows the geographic impact of Keiko Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Okada more than expected).
Fields of papers citing papers by Keiko Okada
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Keiko Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Okada. The network helps show where Keiko Okada may publish in the future.
Co-authorship network of co-authors of Keiko Okada
This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Okada. A scholar is included among the top collaborators of Keiko Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Okada. Keiko Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Noguchi, Toshihiro, Hiroyuki Katoh, Satoshi Nomura, Keiko Okada, & Masahiko Watanabe. (2024). The GLP-1 receptor agonist exenatide improves recovery from spinal cord injury by inducing macrophage polarization toward the M2 phenotype. Frontiers in Neuroscience. 18. 1342944–1342944.
2.
Hama, Asahito, Takashi Taga, Daisuke Tomizawa, et al.. (2023). Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome. British Journal of Haematology. 201(4). 747–756.
3.
Katoh, Hiroyuki, et al.. (2023). Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress. IBRO Neuroscience Reports. 15. 225–234.
4.
Saito, Yuya, Mitsuyoshi Urashima, Yoshiyuki Takahashi, et al.. (2021). Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan. Bone Marrow Transplantation. 56(9). 2173–2182.
5.
Yamasaki, Kai, et al.. (2021). Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Case Reports in Oncology. 14(1). 24–28.
6.
Sakaguchi, Hirotoshi, Takako Miyamura, Daisuke Tomizawa, et al.. (2021). Effect of extramedullary disease on allogeneic hematopoietic cell transplantation for pediatric acute myeloid leukemia: a nationwide retrospective study. Bone Marrow Transplantation. 56(8). 1859–1865.
7.
Yoshida, Nao, Yoshiyuki Takahashi, Hiromasa Yabe, et al.. (2020). Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide. Bone Marrow Transplantation. 55(7). 1272–1281.
8.
Yanagimachi, Masakatsu, Koji Kato, Akihiro Iguchi, et al.. (2020). Hematopoietic Cell Transplantation for Chronic Granulomatous Disease in Japan. Frontiers in Immunology. 11. 1617–1617.
9.
Fukano, Reiji, Tetsuya Mori, Naoto Fujita, et al.. (2019). Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. International Journal of Hematology. 110(6). 723–728.
10.
Yamasaki, Kai, Keiko Okada, Toshinori Soejima, Hiroaki Sakamoto, & Junichi Hara. (2019). Strategy to minimize radiation burden in infants and high‐risk medulloblastoma using intrathecal methotrexate and high‐dose chemotherapy: A prospective registry study in Japan. Pediatric Blood & Cancer. 67(1). e28012–e28012.
11.
Kawashima, Nozomu, Minako Iida, Ritsuro Suzuki, et al.. (2019). Prophylaxis and treatment with mycophenolate mofetil in children with graft-versus-host disease undergoing allogeneic hematopoietic stem cell transplantation: a nationwide survey in Japan. International Journal of Hematology. 109(4). 491–498.
12.
Tomizawa, Daisuke, Masanori Yoshida, Tadakazu Kondo, et al.. (2018). Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases. Bone Marrow Transplantation. 54(3). 393–401.
13.
Umeda, Katsutsugu, Hiromasa Yabe, Koji Kato, et al.. (2018). Impact of low-dose irradiation and in vivo T-cell depletion on hematopoietic stem cell transplantation for non-malignant diseases using fludarabine-based reduced-intensity conditioning. Bone Marrow Transplantation. 54(8). 1227–1236.
14.
Yoshioka, Takakazu, Ryuta Nishikomori, Junichi Hara, et al.. (2013). Autosomal Dominant Anhidrotic Ectodermal Dysplasia with Immunodeficiency Caused by a Novel NFKBIA Mutation, p.Ser36Tyr, Presents with Mild Ectodermal Dysplasia and Non-Infectious Systemic Inflammation. Journal of Clinical Immunology. 33(7). 1165–1174.
15.
Kato, Motohiro, Yoshiyuki Takahashi, Daisuke Tomizawa, et al.. (2013). Comparison of Intravenous with Oral Busulfan in Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Regimens for Pediatric Acute Leukemia. Biology of Blood and Marrow Transplantation. 19(12). 1690–1694.
16.
Sawada, Akihisa, Shouichi Ohga, Eiichi Ishii, et al.. (2013). Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan. International Journal of Hematology. 98(2). 223–230.
17.
Abe, Masanori, et al.. (2010). Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease. International Journal of Clinical Pharmacology and Therapeutics. 48(3). 206–213.
18.
Okada, Keiko, et al.. (2009). Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease. International Journal of Clinical Pharmacology and Therapeutics. 47(8). 525–532.
19.
Okada, Keiko, Junichi Hara, Ichiro Maki, et al.. (2008). Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease. European Journal of Pediatrics. 168(2). 181–185.
20.
Ichida, Shizunori, et al.. (2006). Bone marrow transplant nephropathy successfully treated with angiotensin-converting enzyme inhibitor. Clinical and Experimental Nephrology. 10(1). 78–81.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Henry Hui Breakdown of academic impact, for papers by Laura Rodríguez‐Romo Breakdown of academic impact, for papers by Toshio Kakihara Breakdown of academic impact, for papers by Toshiaki Ishida Breakdown of academic impact, for papers by Nozomu Kawashima Breakdown of academic impact, for papers by Jung Yeon Lee Breakdown of academic impact, for papers by Djuna Z. de Back Breakdown of academic impact, for papers by S Miyazaki Breakdown of academic impact, for papers by Emily K. Thomas Breakdown of academic impact, for papers by Takamitsu Matsushima